The pharmacology of L-DOPA-induced dyskinesia in Parkinson's disease

P Huot, TH Johnston, JB Koprich, SH Fox… - Pharmacological …, 2013 - ASPET
l-3, 4-Dihydroxyphenylalanine (l-DOPA) remains the most effective symptomatic treatment of
Parkinson's disease (PD). However, long-term administration of l-DOPA is marred by the …
被引用次数：369 相关文章

The pharmacology of L-DOPA-induced dyskinesia in Parkinson's disease

P Huot, TH Johnston, JB Koprich… - Pharmacological …, 2013 - pubmed.ncbi.nlm.nih.gov
L-3, 4-Dihydroxyphenylalanine (L-DOPA) remains the most effective symptomatic treatment
of Parkinson's disease (PD). However, long-term administration of L-DOPA is marred by the …

The pharmacology of L-DOPA-induced dyskinesia in Parkinson's disease.

P Huot, TH Johnston, JB Koprich, SH Fox… - Pharmacological …, 2013 - europepmc.org
L-3, 4-Dihydroxyphenylalanine (L-DOPA) remains the most effective symptomatic treatment
of Parkinson's disease (PD). However, long-term administration of L-DOPA is marred by the …

[引用][C] The Pharmacology of l-DOPA-Induced Dyskinesia in Parkinson's Disease

P Huot, TH Johnston, JB Koprich, SH Fox… - Pharmacological …, 2013 - cir.nii.ac.jp
The Pharmacology of l-DOPA-Induced Dyskinesia in Parkinson’s Disease | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
[PDF] researchgate.net

[PDF][PDF] The Pharmacology of L-DOPA-Induced Dyskinesia in Parkinson's Disease

ASD Denervation - PHARMACOLOGICAL REVIEWS, 2013 - researchgate.net
L-3, 4-Dihydroxyphenylalanine (L-DOPA) remains the most effective symptomatic treatment
of Parkinson's disease (PD). However, long-term administration of L-DOPA is marred by the …